| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.75B | 3.20B | 2.77B | 3.82B | 3.61B |
| Gross Profit | 576.70M | 580.40M | 795.10M | 867.50M | 1.08B |
| EBITDA | 437.20M | 393.00M | 385.30M | 738.20M | 973.50M |
| Net Income | 285.70M | 267.10M | 255.40M | 561.00M | 787.20M |
Balance Sheet | |||||
| Total Assets | 5.32B | 4.83B | 4.79B | 5.03B | 4.79B |
| Cash, Cash Equivalents and Short-Term Investments | 117.00M | 258.60M | 420.10M | 861.60M | 1.25B |
| Total Debt | 16.80M | 453.60M | 392.70M | 498.00M | 436.90M |
| Total Liabilities | 1.70B | 1.33B | 1.37B | 1.59B | 1.17B |
| Stockholders Equity | 3.61B | 3.51B | 3.42B | 3.44B | 3.63B |
Cash Flow | |||||
| Free Cash Flow | -12.00M | 52.60M | -166.20M | 371.80M | 763.90M |
| Operating Cash Flow | 28.60M | 84.90M | -129.80M | 402.30M | 784.80M |
| Investing Cash Flow | 26.80M | -45.00M | -42.90M | -29.80M | -18.20M |
| Financing Cash Flow | -197.00M | -201.40M | -268.80M | -757.50M | -754.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £3.22B | 5.48 | 10.20% | 6.38% | -6.44% | -0.03% | |
67 Neutral | £3.60B | 13.20 | 2.73% | 4.73% | 33.83% | 15.11% | |
63 Neutral | £3.06B | 37.90 | 2.40% | 8.95% | 4.21% | -65.57% | |
62 Neutral | £2.10B | 8.04 | 4.45% | 2.62% | 16.91% | 20.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | £3.45B | 15.22 | 8.05% | 4.54% | 16.74% | -0.16% | |
54 Neutral | £1.09B | 15.19 | 4.20% | ― | -0.57% | -104.08% |